In silico Tools at Early Stage of Pharmaceutical Development: Data Needs and Software Capabilities
暂无分享,去创建一个
Gregory K. Webster | Dwaipayan Mukherjee | Juliet Obianuju Njoku | Daniela Amaral Silva | Raimar Löbenberg | R. Löbenberg | J. Njoku | Dwaipayan Mukherjee | Daniela Amaral Silva | G. K. Webster
[1] M. Caldwell,et al. Prospective Hematologic Evaluation of Gastric Exclusion Surgery for Morbid Obesity , 1985, Annals of surgery.
[2] Haitao Wang,et al. The Nerve Growth Factor Signaling and Its Potential as Therapeutic Target for Glaucoma , 2014, BioMed research international.
[3] Shoufeng Li,et al. Biorelevant test for supersaturable formulation , 2016, Asian journal of pharmaceutical sciences.
[4] John Crison,et al. From Bench to Humans: Formulation Development of a Poorly Water Soluble Drug to Mitigate Food Effect , 2014, AAPS PharmSciTech.
[5] J. Crison,et al. A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] Raimar Löbenberg,et al. Simulation of In Vitro Dissolution Behavior Using DDDPlus™ , 2014, AAPS PharmSciTech.
[7] Shaofei Xie,et al. DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles , 2010, The AAPS Journal.
[8] R. Löbenberg,et al. Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification , 2017 .
[9] Andre Hermans,et al. Dissolution Testing in Drug Product Development: Workshop Summary Report , 2019, The AAPS Journal.
[10] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] Yuan Gao,et al. Evaluation of the DDSolver Software Applications , 2014, BioMed research international.
[12] Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System , 2017, The AAPS Journal.
[13] L. Wienkers,et al. Characterization of Ritonavir-Mediated Inactivation of Cytochrome P450 3A4 , 2014, Molecular Pharmacology.
[14] G. Amidon,et al. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] W R Porter,et al. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. , 2001, Journal of pharmaceutical sciences.
[16] Filippos Kesisoglou,et al. Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report , 2018, The AAPS Journal.
[17] Colin W Pouton,et al. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[19] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[20] R. Löbenberg,et al. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] V. Shah,et al. Steps for Development of a Dissolution Test for Sparingly Water-Soluble Drug Products , 2000 .
[22] P. Gao,et al. In vitro characterization of ritonavir formulations and correlation to in vivo performance in dogs , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Judith C. Madden,et al. In Silico Prediction of Aqueous Solubility: The Solubility Challenge , 2009, J. Chem. Inf. Model..
[24] N. Davies,et al. Application of in Silico Tools in Clinical Practice using Ketoconazole as a Model Drug. , 2018, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[25] J. Mönkkönen,et al. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[26] P. Marroum,et al. In Vitro Characterization of Ritonavir Drug Products and Correlation to Human in Vivo Performance. , 2017, Molecular pharmaceutics.
[27] Guilan Quan,et al. Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole , 2018, Pharmaceutics.
[28] Kazutaka Higaki,et al. In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[29] L. S. Taylor,et al. Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations , 2013 .
[30] Raimar Löbenberg,et al. Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[31] N. Pavlović,et al. Application of bile acids in drug formulation and delivery , 2013 .
[32] R. Löbenberg,et al. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models , 2017, Drug design, development and therapy.